Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Prestige Consumer Healthcare Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 286
- +19 vs. Q4 2021
- Shares held
- 50.4M
- −162.7K (−0.3%) vs. Q4 2021
- Total value
- $2.67B
- −$397.0M (−13.0%) vs. Q4 2021
- New holders
- 43
- 117 more added
- Sold out
- 24
- 87 more reduced
4 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.54B |
| Q1 2026 | 354 | $3.08B |
| Q4 2025 | 354 | $3.18B |
| Q3 2025 | 356 | $3.17B |
| Q2 2025 | 377 | $4.16B |
| Q1 2025 | 358 | $4.44B |
| Q4 2024 | 337 | $4.10B |
| Q3 2024 | 327 | $3.68B |
| Q2 2024 | 305 | $3.51B |
| Q1 2024 | 312 | $3.72B |
| Q4 2023 | 288 | $3.13B |
| Q3 2023 | 280 | $2.91B |
| Q2 2023 | 278 | $2.97B |
| Q1 2023 | 283 | $3.16B |
| Q4 2022 | 288 | $3.13B |
| Q3 2022 | 276 | $2.49B |
| Q2 2022 | 285 | $2.98B |
| Q1 2022 | 286 | $2.67B |
| Q4 2021 | 271 | $3.07B |
| Q3 2021 | 248 | $2.85B |
| Q2 2021 | 227 | $2.71B |
| Q1 2021 | 240 | $2.32B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Prestige Consumer Healthcare Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Partners LLC | 0 | $0 | 0.00% | −3,444−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −3,364−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −3,107−100.0% | Sold out |
| Islay Capital Management, LLC | 0 | $0 | 0.00% | −2,123−100.0% | Sold out |
| Signet Financial Management, LLC | 0 | $0 | 0.00% | −1,306−100.0% | Sold out |
| Fuller & Thaler Asset Management, Inc. | 0 | $0 | 0.00% | −285−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −201−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| McDonald Partners LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Absolute Capital Management, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| 6 Meridian | – | – | – | – | Not filed |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |